10.1038/s41586-020-2012-7
10.1038/s41586-020-2008-3
10.1038/s41467-020-17665-9
10.1016/j.bbrc.2020.04.136
Chinese
Center for Disease Control Prevention. Specific primers and probes
for detection 2019 novel coronavirus. http://ivdc.chinacdc.cn/kyjz/202001/t20200121_211337.html (accessed on 2020/08/16).
Corman V. M., 2020, Euro Surveill., 25, 2000045
Institut
Pasteur, Paris. Protocol: Real-time RT-PCR assays for the detection
of SARS-CoV-2. https://www.who.int/docs/default-source/coronaviruse/real-time-rt-pcr-assays-for-the-detection-of-sars-cov-2-institut-pasteur-paris.pdf?sfvrsn=3662fcb6_2 (accessed on 2020/08/16).
Centers
for Disease Control and Prevention. 2019-Novel Coronavirus (2019-nCoV)
Real-time rRT-PCR Panel Primers and Probes. https://www.cdc.gov/coronavirus/2019-ncov/downloads/rt-pcr-panel-primer-probes.pdf (accessed on 2020/08/16).
10.1186/s12879-020-05484-8
10.1007/s12250-020-00218-1
10.1080/22221751.2020.1756698
10.1016/j.cmi.2020.04.001
10.1101/2020.02.26.20028373
10.1016/j.jmoldx.2020.03.006
10.1080/22221751.2020.1772679
10.1080/22221751.2020.1772678
10.1038/s41587-020-0513-4
10.1016/j.bios.2020.112316
10.1038/s41551-020-00603-x
10.1038/s41421-020-0174-y
10.1016/j.cell.2020.04.011
10.1101/2020.10.15.20212712
10.1016/j.snb.2020.128899
10.1016/j.bios.2020.112437
10.1016/j.bios.2020.112479
10.1016/S0140-6736(20)30251-8
10.1016/S0140-6736(20)30154-9
Chan J. F., 2020, J. Clin. Microbiol., 58, e00310
Nalla A. K., 2020, J. Clin. Microbiol., 58, e00557, 10.1128/JCM.00557-20
10.2807/1560-7917.ES.2020.25.9.2000152
10.1038/s41467-020-18575-6
World
Health Organization. Molecular assays to diagnose
COVID-19: summary table
of available protocols. https://www.who.int/publications/m/item/molecular-assays-to-diagnose-covid-19-summary-table-of-available-protocols (accessed on 2020/08/16).
10.1148/radiol.2020200642
10.1016/j.cca.2020.03.009
10.1016/j.jcv.2020.104346
10.1038/s41591-020-0869-5
10.1016/S1473-3099(20)30232-2
10.1001/jamapediatrics.2020.3651
10.1038/s41598-020-68782-w
World
Health Organization. Laboratory testing for
coronavirus disease (COVID-19)
in suspected human cases: interim guidance, 19 March 2020. https://www.who.int/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspected-human-cases-20200117 (accessed on 2020/08/16).
World Health Organization. Laboratory biosafety guidance related to coronavirus
disease (COVID-19): interim guidance, 13 May 2020. https://www.who.int/publications/i/item/laboratory-biosafety-guidance-related-to-coronavirus-disease-(covid-19) (accessed on 2020/08/16).
10.1016/j.bios.2020.112274
10.1183/13993003.00763-2020
10.1080/14737159.2020.1757437
10.1007/s10096-020-03899-4
10.1016/j.rbmo.2020.06.001
10.1021/acs.analchem.0c02060
10.1080/22221751.2020.1745095
10.3390/diagnostics10040202
10.1016/j.bios.2020.112673
10.1016/j.jcv.2020.104455
10.1021/acs.analchem.0c01975
10.1021/acs.analchem.0c01635
10.1016/j.ijid.2020.08.029
10.3390/diagnostics10080594
10.1016/j.bios.2020.112686
10.1021/acscentsci.0c00501
World
Health Organization. Advice on the use of
point-of-care immunodiagnostic
tests for COVID-19: scientific brief, 8 April 2020. https://apps.who.int/iris/handle/10665/331713 (accessed on 2020/08/16).
10.1016/S0140-6736(20)31483-5
10.1038/s41591-020-0949-6
10.1016/S0140-6736(20)31482-3
Isho B., 2020, Sci. Immunol., 5, eabe5511, 10.1126/sciimmunol.abe5511
10.1016/j.immuni.2020.07.020
10.1016/j.immuni.2020.04.023
10.1038/s41586-020-2380-z
10.1038/s41586-020-2548-6
10.1038/s41577-020-00434-6
10.1038/s41541-020-00221-3
10.1016/S1473-3099(20)30273-5
10.1038/s41564-020-00813-8
10.2807/1560-7917.ES.2020.25.16.2000421
10.1101/2020.06.11.20128686
Klimov A., 2012, Influenza Virus: Methods and Protocols, 25, 10.1007/978-1-61779-621-0_3
World Health
Organization. Serological detection of avian
influenza A(H7N9)
infections by microneutralization assay. https://www.who.int/influenza/gisrs_laboratory/cnic_serological_diagnosis_microneutralization_a_h7n9.pdf?ua=1 (accessed on 2020/08/20).
10.1080/22221751.2020.1743767
10.1038/s41587-020-0631-z
Liu W., 2020, J. Clin. Microbiol., 58, e00461
10.1038/s41591-020-0913-5
10.1038/s41420-020-0275-2
10.1101/2020.03.17.20036954
10.1038/s41467-020-17317-y
10.1016/j.jinf.2020.03.051
10.1016/j.puhe.2020.04.009
10.1007/s10096-020-03978-6
10.1016/j.jcv.2020.104394
10.1038/s41467-020-17488-8
10.1021/acscentsci.0c00742
10.1016/j.bios.2020.112578
10.2807/1560-7917.ES.2020.25.11.2000266
10.1016/j.cmi.2020.06.024
10.1021/acssensors.0c00927
10.1101/2020.07.21.20159392
10.1016/j.jcv.2020.104540
10.1016/j.cmi.2020.05.028
10.1016/S0140-6736(20)31830-4
10.5858/arpa.2020-0499-SA
10.1016/j.jcv.2020.104549
10.1016/j.jcv.2020.104613
10.1038/s41551-020-00611-x
10.1016/j.jim.2015.04.017
10.1016/j.jim.2012.02.011
10.1038/d41587-020-00010-2
10.3390/diagnostics10070453
US
Food and Drug Administration. Policy for Coronavirus Disease-2019
Tests During the Public Health Emergency (Revised). https://www.fda.gov/media/135659/download (accessed on 2020/11/08).
10.1038/s41591-020-0897-1
10.3390/diagnostics10050319
10.1038/d41586-020-01115-z
European
Centre for Disease
Prevention and Control. An overview of the
rapid test situation for COVID-19 diagnosis in the EU/EEA. https://www.ecdc.europa.eu/sites/default/files/documents/Overview-rapid-test-situation-for-COVID-19-diagnosis-EU-EEA.pdf (accessed on 2020/08/20).
10.1371/journal.pone.0240775
10.1007/s13206-019-3103-0
10.1007/s00604-015-1623-4
10.1080/15321818308057011
10.1016/j.tetlet.2015.03.065
10.1016/j.chembiol.2020.06.016
Hosseini S., 2018, Enzyme-linked Immunosorbent Assay (ELISA): From A to Z, 31
10.1016/S1473-3099(20)30196-1
10.1016/j.celrep.2021.108728
10.1080/22221751.2020.1762515
Infantino M., 2020, Isr. Med. Assoc. J., 22, 203
10.1038/s41467-020-15562-9
10.1016/j.jcv.2020.104569
10.1016/j.ijid.2020.03.065
10.1016/0022-5193(82)90080-7
10.1183/13993003.01526-2020
10.1016/j.jinf.2020.04.033
10.1101/2020.06.07.20124636
10.1016/j.jcv.2020.104575
10.1016/j.cca.2020.04.026
10.1016/j.micinf.2020.05.008
10.1101/2020.03.24.20042382
10.1080/22221751.2020.1756699
10.1016/j.jinf.2020.04.019
10.1016/j.celrep.2020.107725
Zheng Z., 2020, Euro Surveill., 25, 2000291, 10.2807/1560-7917.ES.2020.25.28.2000291
10.1101/2020.06.22.20137695
10.1016/j.xcrm.2020.100189
10.1038/s41564-020-0688-y
10.1038/s41467-020-16256-y
10.1101/2020.03.24.006544
10.1101/2020.07.27.222943
10.1016/S2665-9913(20)30128-4
10.1016/j.clim.2020.108480
Polifke, T.; Rauch, P. The Covid-19 antibody test challenge. https://youraccount.27.ekm.net/ekmps/shops/bioaxxess/resources/Other/candor-bioscience-elisa-plateblock-for-covid-19-antibody-test-challenge-bioaxxess.pdf (accessed on 2020/09/24).
Green, K.; Graziadio, S.; Turner, P.; Fanshawe, T.; Allen, J. Molecular and antibody point-of-care tests to support the screening, diagnosis and monitoring of COVID-19. https://www.cebm.net/wp-content/uploads/2020/04/POCT-Covid19.pdf (accessed on 2020/07/29).
10.1002/(SICI)1097-0258(19970515)16:9<981::AID-SIM510>3.0.CO;2-N
10.1021/acs.analchem.0c04034
10.1038/s41423-020-0385-z
10.1101/2020.07.17.20156000
10.1101/2020.09.01.20182220
10.1016/j.matt.2020.09.027
10.1038/s41591-020-0891-7
